HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

lifastuzumab vedotin

humanized anti-NaPi2b monoclonal antibody conjugated to a potent antimitotic agent, monomethyl auristatin E
Also Known As:
DNIB0600A
Networked: 3 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Choi, YounJeong: 2 articles (01/2020 - 01/2020)
2. Cordova, Julie: 2 articles (01/2020 - 01/2020)
3. Humke, Eric W: 2 articles (01/2020 - 01/2020)
4. Lemahieu, Vanessa: 2 articles (01/2020 - 01/2020)
5. Maslyar, Daniel: 2 articles (01/2020 - 01/2020)
6. Royer-Joo, Stephanie: 2 articles (01/2020 - 01/2020)
7. Samineni, Divya: 2 articles (01/2020 - 01/2020)
8. Schuth, Eva: 2 articles (01/2020 - 01/2020)
9. Vaze, Anjali: 2 articles (01/2020 - 01/2020)
10. Wang, Yulei: 2 articles (01/2020 - 01/2020)

Related Diseases

1. Ovarian Neoplasms (Ovarian Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

Related Drugs and Biologics

1. lifastuzumab vedotin
2. Immunoconjugates (Immunoconjugate)
3. Platinum
4. liposomal doxorubicin (Doxil)